Two classes of GGAA-microsatellites in a Ewing sarcoma context

November 1, 2017, Nationwide Children's Hospital

In a study published in PLOS ONE, researchers describe two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma. Ewing sarcoma is the second most common pediatric bone malignancy. It is initiated by chromosomal translocation t(11;22)(q24;q12), which creates the fusion protein and oncogenic driver EWS/FLI.

"The work to understand the subtleties of how the EWS/FLI and GGAA-microsatellites interact to drive oncogenesis is foundational to our ability to develop new therapeutics against transcription factor-driven cancers," says Stephen Lessnick, MD, PhD, director of the Center for Childhood Cancer and Blood Diseases at Nationwide Children's and senior author of the publication. "Here, we sought to define GGAA-microsatellites in a Ewing sarcoma context and understand their role across the genome."

In their work, Dr. Lessnick and his team used bioinformatics analysis of experimental data in an unbiased genome-wide approach. Then, they computationally linked bound microsatellites to adjacent EWS/FLI regulated . That data revealed two distinct types of GGAA-microsatellites: "promoter-like" (close-range) and "enhancer-like" (long-range).

According to the study, EWS/FLI binding and gene activation at promoter-like microsatellites is highly dependent on the length of GGAA motifs.

At long range, enhancer-like microsatellites demonstrate length-dependent EWS/FLI binding, but the researchers found minimal correlation for activation and none for repressed targets. Here, the number of GGAA-motifs positively correlates with EWS/FLI binding, but not with gene expression.

Further investigation into how EWS/FLI associates with GGAA-microsatellites to drive transcription was the subject of a recent study published in Proceedings of the National Academy of Sciences. Both studies highlight the importance of microsatellite length in oncogenic function.

"Microsatellite length and location appears to be essential for EWS/FLI to activate the oncogenic gene targets," says Dr. Lessnick. "Our results have revealed and characterized two classes of GGAA-microsatellites that suggest unique interactions and distinct regulatory mechanisms for distance-dependent activation and repressions. This characterization contributes insight into EWS/FLI transcription factor biology and clarifies the role of GGAA-microsatellites on a global genomic scale."

Explore further: A new paradigm for treating transcription factor-driven cancers

More information: PLOS ONE (2017). DOI: 10.1371/journal.pone.0186275

Related Stories

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

A noncoding RNA promotes pediatric bone cancer

November 17, 2014
Ewing sarcoma is a cancer of bone or its surrounding soft tissue that primarily affects children and young adults. A hallmark of Ewing sarcoma is a translocation event that results in the fusion of an RNA binding protein, ...

DNA structures called microsatellites play a greater role in cancer than previously thought

October 4, 2016
Short, unstable stretches of DNA, called microsatellites, may play a far greater role in the development and progression of cancer than previously thought, UW Medicine researchers report in a study appearing Oct. 3 in the ...

Single genetic abnormality accelerates, removes the brakes on Ewing sarcoma tumor growth

December 16, 2014
The genetic abnormality that drives the bone cancer Ewing sarcoma operates through two distinct processes - both activating genes that stimulate tumor growth and suppressing those that should keep cancer from developing. ...

Recommended for you

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018
Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

Study finds melanoma biomarkers predicting checkpoint blocker response

July 18, 2018
Scientists at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood ...

Link found between bitter-taste sensitivity and cancer risk

July 18, 2018
High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been ...

Scientists discover a mechanism of drug resistance in breast and ovarian cancer

July 18, 2018
There is a highly sophisticated way to treat some breast and ovarian cancers—a class of drugs called PARP inhibitors, designed to exploit the very defects that make tumors with certain mutations especially deadly. Yet this ...

Early supper associated with lower risk of breast and prostate cancer

July 18, 2018
Having an early supper or leaving an interval of at least two hours before going to bed are both associated with a lower risk of breast and prostate cancer. Specifically, people who take their evening meal before 9 p.m. or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.